GSDMD and chronic kidney disease: However, 2 important questions remained: (a) do CKD and CVD accelerate vascular inflammation via enhancing TI in aortic vascular cells, and (b) is the noncanonical inflammasome signaling (CASP4/11-GSDMD-IL1B) the underlying molecular mechanisms of TI in CKD and CVD?